Send to

Choose Destination
Memo. 2017;10(1):8-12. doi: 10.1007/s12254-017-0318-4. Epub 2017 Feb 27.

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.

Author information

3rd Medical Department, Paracelsus Private Medical University Hospital Salzburg, Muellnerhauptstrasse 48, 5020 Salzburg, Austria.


The past 10 years have been an exciting ride for Chronic Lymphocytic Leukemia (CLL) aficionados. An overview of changes in management paradigms in CLL, ranging from insights into biology, via chemotherapy and chemoimmunotherapy to maintenance and novel drugs will be presented.


Chemoimmunotherapy; Chronic Lymphocytic Leukemia; Ibrutinib; Idelalisib; Minimal Residual Disease; Venetoclax

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center